17.48

0.23% 0.04

Seres Therapeutics Inc (MCRB)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$17.44

Offen:

$17.5

24-Stunden-Volumen:

79,869

Relative Volume:

0.36

Marktkapitalisierung:

$158.13M

Einnahmen:

$123.24M

Nettoeinkommen (Verlust:

$136.00K

KGV:

-874.00

EPS:

-0.02

Netto-Cashflow:

$-148.99M

1W Leistung:

+3.62%

1M Leistung:

+27.13%

6M Leistung:

+145.16%

1J Leistung:

+6.72%

1-Tages-Spanne:

$16.80

$17.90

1-Wochen-Bereich:

$16.61

$18.86

52-Wochen-Spanne:

$6.53

$29.98

Seres Therapeutics Inc Stock (MCRB) Company Profile

Firmenname

Seres Therapeutics Inc

Sektor

Healthcare (1131)

Branche

Biotechnology (632)

Telefon

617 945 9626

Adresse

200 SIDNEY STREET, CAMBRIDGE, MA

Mitarbeiter

103

Twitter

@SeresTX

Nächster Verdiensttermin

2024-10-31

Neueste SEC-Einreichungen

MCRB's Discussions on Twitter

Vergleichen Sie MCRB mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MCRB Seres Therapeutics Inc	17.48	157.77M	123.24M	136.00K	-148.99M	-0.02
VRTX Vertex Pharmaceuticals Inc	457.26	117.50B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	722.83	76.06B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	464.56	62.53B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	916.31	56.75B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	205.04	44.10B	447.02M	-1.18B	-906.14M	-6.1812

Seres Therapeutics Inc Stock (MCRB) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-05-08	Herabstufung	Chardan Capital Markets	Buy → Neutral
2024-10-24	Herabstufung	JP Morgan	Neutral → Underweight
2023-06-26	Fortgesetzt	Oppenheimer	Outperform
2023-04-21	Eingeleitet	JP Morgan	Neutral
2021-07-23	Herabstufung	Goldman	Neutral → Sell
2021-05-18	Fortgesetzt	Goldman	Neutral
2021-03-05	Hochstufung	Chardan Capital Markets	Neutral → Buy
2020-09-18	Herabstufung	Chardan Capital Markets	Buy → Neutral
2020-08-18	Eingeleitet	Piper Sandler	Overweight
2020-08-11	Bestätigt	H.C. Wainwright	Buy
2020-08-11	Hochstufung	Jefferies	Hold → Buy
2019-04-30	Eingeleitet	Jefferies	Hold
2018-10-22	Eingeleitet	Chardan Capital Markets	Buy
2017-10-13	Eingeleitet	Oppenheimer	Outperform
2017-08-04	Bestätigt	H.C. Wainwright	Buy
2017-02-01	Bestätigt	FBR & Co.	Outperform
2016-08-12	Bestätigt	FBR Capital	Outperform
2016-08-01	Herabstufung	BofA/Merrill	Buy → Neutral
2016-08-01	Bestätigt	H.C. Wainwright	Buy
2016-07-29	Fortgesetzt	H.C. Wainwright	Buy
2016-03-30	Eingeleitet	FBR Capital	Outperform
2016-03-03	Eingeleitet	Guggenheim	Buy
2016-01-25	Eingeleitet	H.C. Wainwright	Buy
2015-10-22	Hochstufung	BofA/Merrill	Neutral → Buy
2015-07-22	Eingeleitet	Canaccord Genuity	Buy
2015-07-21	Eingeleitet	Goldman	Neutral
2015-07-21	Eingeleitet	Leerink Partners	Outperform

Alle ansehen

Seres Therapeutics Inc Aktie (MCRB) Neueste Nachrichten

04:17 AM

Seres Therapeutics (NASDAQ:MCRB) Stock Passes Below 50 Day Moving AverageHere's What Happened - MarketBeat

04:17 AM

Dec 03, 2025

Will Seres Therapeutics Inc. (1S90) stock outperform foreign stocksWeekly Risk Summary & Real-Time Chart Pattern Alerts - Newser

Dec 03, 2025

Will Seres Therapeutics Inc. (1S90) stock beat value stocks2025 Year in Review & Verified Chart Pattern Signals - Newser

Dec 03, 2025

Dec 02, 2025

What market sentiment indicators show for Seres Therapeutics Inc. (1S90) stock2025 Institutional Moves & Free Daily Entry Point Trade Alerts - Newser

Dec 02, 2025

What risks investors should watch in Seres Therapeutics Inc. stock2025 Volatility Report & AI Driven Stock Movement Reports - Newser

Dec 02, 2025

Is Seres Therapeutics Inc. stock dividend yield sustainablePortfolio Update Report & Growth Oriented Trade Recommendations - Newser

Dec 02, 2025

Is Seres Therapeutics Inc. stock positioned for long term growth2025 Support & Resistance & Growth Focused Stock Pick Reports - Newser

Dec 02, 2025

Dec 01, 2025

Seres Therapeutics (MCRB) Stock Analysis Report | Financials & Insights - Benzinga

Dec 01, 2025

Nov 28, 2025

Volatility Watch: Why Seres Therapeutics Inc. stock is rated strong buyJuly 2025 Review & High Accuracy Trade Alerts - moha.gov.vn

Nov 28, 2025

Nov 27, 2025

A look into Seres Therapeutics Inc (MCRB)’s deeper side - Setenews

Nov 27, 2025

Why Seres Therapeutics Inc. stock is rated strong buyMarket Performance Report & Fast Exit Strategy with Risk Control - BỘ NỘI VỤ

Nov 27, 2025

Is Seres Therapeutics Inc. stock affected by interest rate hikesTrade Entry Summary & Target Return Focused Picks - BỘ NỘI VỤ

Nov 27, 2025

Nov 24, 2025

Seres Therapeutics to Participate in Piper Sandler Healthcare Conference - The Manila Times

Nov 24, 2025

Seres Therapeutics (Nasdaq: MCRB) to join Piper Sandler 37th Annual Healthcare Conference - Stock Titan

Nov 24, 2025

Nov 22, 2025

Seres Therapeutics Inc Stock Analysis and ForecastHead and Shoulders Patterns & Big Gains Low Cost - earlytimes.in

Nov 22, 2025

Nov 21, 2025

What analysts say about Seres Therapeutics Inc stockMACD Histogram Signals & Budget Friendly Capital Growth - earlytimes.in

Nov 21, 2025

Should You Watch Rane Engine Valve Limited for Sector Rotation UpsideWeekly Market Snapshot & Free Stock Market Mentorship Programs - earlytimes.in

Nov 21, 2025

Can Poonawalla Fincorp Limited Deliver Consistent Free Cash FlowsMarket Depth Overview & Swing Trade Smarter With Data Insights - earlytimes.in

Nov 21, 2025